Home › Pulmonary Arterial Hypertension › Kansas › Kansas City
Pulmonary Arterial Hypertension clinical trials in Kansas City, KS
7 studies for Pulmonary Arterial Hypertension are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- USA010, Kansas City
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
RecruitingPhase 3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
RecruitingPhase 2
- The University of Kansas Medical Center Research Institute, Kansas City
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
RecruitingPhase 3
- University of Kansas Medical Center, Kansas City
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
RecruitingPhase 1/2Healthy volunteers welcome
- U of Kansas Medical Center, Kansas City
Pulmonary Hypertension Association Registry
RecruitingObservational study
- KU Medical Center, Kansas City
Pulmonary Hypertension Biorepository and Registry
RecruitingObservational study
- University of Kansas Medical Center, Kansas City
Pulmonary Arterial Hypertension trials in other cities
- Durham, NC7 studies
- Mountain View, CA7 studies
- Cincinnati, OH7 studies
- Boston, MA7 studies
- Aurora, CO7 studies
- Nashville, TN7 studies
- Philadelphia, PA6 studies
- New York City, NY5 studies
- Seattle, WA5 studies
- Pittsburgh, PA4 studies
- Louisville, KY4 studies
- Dallas, TX4 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.